Cardiac Rhythm Management Research Group
Our group is headed by Professor Paul Roberts. Our co-investigators are consultant electrophysiologists:
Artificial Intelligence (AI) in electrocardiogram (ECG) interpretation
We develop screening strategies using digital Holter monitors to evaluate relative amplitudes of P wave, QRS complexes and T waves. Our strategies allow us to identify specific patients suitable for non-transvenous implantable cardioverter defibrillators (ICDs).
Most ICDs have leads within the blood vessels to the heart. If devices misinterpret ECGs, they can lead to inappropriate treatment (shocks). Partnering with Mathematical Sciences and Electronic and Computer Science, we have developed complex neural networks to evaluate ECGs quickly and accurately.
We use AI algorithms to automatically interpret and classify 12 lead ECGs. This technology has great potential to more accurately diagnose patients on the basis of ECGs. In collaboration with industry partners, we assess these algorithms in primary care and emergency departments (ED).
Leadless pacemakers
We lead the implantation of leadless pacemakers. New designs avoid the complications of conventional transvenous devices.
Our work on this therapy is widely published.
New technologies for ablation of arrhythmias
We examine the use of different 3D electro anatomical mapping systems to ablate abnormal cardiac rhythms (arrhythmias), such as atrial fibrillation and ventricular tachycardia.
In collaboration with industry partners, we use complex algorithms deployed in current clinical mapping systems. We examine the impact of mapping and ablation of arrhythmias to improve outcomes.
Can we get a clarification about which is the new technology – trans septal puncture techniques or pulse field ablation – and which one of these techniques it is that is being evaluated for impact and safety.
New technology allows us to access the left atrium using trans septal puncture techniques. We have investigated potential benefits, such as workflow (time) and safety. With the advent of pulsed field ablation, we are evaluating the impact and safety of these techniques.
Services to business or government
- advisory roles to national organisations e.g. NICE, NHSE and MHRA
- clinical partnership with cardiac device-based industry, such as human implants of devices
Work with partner organisations
We undertake collaborative research with the School of Mathematical Sciences and the School of Electronics and Computer Science.
Our clinical and research collaborations with medical device-based businesses include:
- Medtronic
- Boston Scientific
- Abbott Medical
- Johnson and Johnson
- EBR systems
- Powerful Medical